3.2.1.127	additional information	-	5.5 micromol/min/l, progressive disease group	699825	
3.2.1.127	additional information	-	5.9 micromol/min/l, nonresponders to trastuzumab	699825	
3.2.1.127	additional information	-	6.1 micromol/min/l, spectrophotometer citrate buffer pH 4.5, 3 h incubation at 37 degree Celsius, optical density at 405 nm, average over all patient	699825	
3.2.1.127	additional information	-	6.3 micromol/min/l, non-progressive disease group	699825	
3.2.1.127	additional information	-	7.2 micromol/min/l, responders to trastuzumab	699825	
3.2.1.127	0.000000606	-	-	646707